Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Pozycja w akcjach #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Cena akcji
$0.00060315
Ostatnia synchronizacja: 2024-09-27
Kapitalizacja rynkowa
$1.65M
Zmiana (1 dzień)
19.64%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel Amniotics AB (publ) (AMNI)

Kategoria

Historia ceny akcji dla Amniotics AB (publ) (AMNI)
Najwyższa cena zamknięcia: $0.00 dnia 2024-09-01

Najniższa cena zamknięcia: $0.46 dnia 2021-07-01
Historia cen akcji firmy Amniotics AB (publ) od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 -42.96%
2023 -98.38%
2022 -87.58%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE